FDA Warns On Fisher & Paykel Healthcare’s Infant CPAP Systems Following Dozens Of Complaints

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FDA regulators put their highest-risk warning on Fisher & Paykel Healthcare’s recall of infant CPAP prongs after receiving complaints that they detached from their tubing. FDA regulators put their highest-level warning on Fisher & Paykel’s recall of infant CPAP components, warning that the defect may pose a choking risk to babies. F&P initiated the recall last month after receiving 24 reports that infant nasal CPAP prongs had malfunctioned.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC